Dieter, AA, Willis-Gray, MG, Weidner, AC, Visco, AG, and Myers, ER. "Vaginal native tissue repair versus transvaginal mesh repair for apical prolapse: how utilizing different methods of analysis affects the estimated trade-off between reoperation for mesh exposure/erosion and reoperation for recurrent prolapse." International urogynecology journal 26, no. 5 (May 2015): 721-727.
Alison Catherine Weidner, MD
I am an active clinician/researcher treating women with various forms of pelvic floor dysfunction throughout my career. I maintain a busy clinical practice and particularly enjoy and excel at clinical and surgical training of Iearners at all levels in the medical setting.
Early in my career I designed and executed innovative clinical research with broad-reaching impact on our knowledge of the mechanism of neuromuscular injury to the pelvic floor and its ultimate contribution to pelvic floor dysfunction. Currently, my clinical research efforts are dedicated to designing and implementing innovative studies with other investigators within the NICHD-funded Pelvic Floor Disorders Network with direct influence on clinical management of common pelvic disorders.
Education and Training
- Resident, Obstetrics & Gynecology, Children's Hospital Boston, 1992 - 1996
- M.D., Duke University, 1992
- Female pelvic floor dysfunction
- Urinary incontinence
- Pelvic organ prolapse
- Maternal birth trauma
- Pelvic neuromuscular function
Selected Grants and Awards
Markland, A, Wang, L, Jelovsek, JE, Brubaker, L, Tuteja, A, Weidner, AC, LoSavio, A, Corton, M, Meikle, S, and Richter, HE. "Symptom improvement in women after fecal incontinence treatments: a multicenter cohort study of the pelvic floor disorders network." Female pelvic medicine & reconstructive surgery 21, no. 1 (January 2015): 46-52.
Brubaker, L, Nager, CW, Richter, HE, Weidner, AC, Hsu, Y, Wai, CY, Paraiso, M, Nolen, TL, Wallace, D, Meikle, S, and NICHD Pelvic Floor Disorders Network, . "Effectiveness of blinding: sham suprapubic incisions in a randomized trial of retropubic midurethral sling in women undergoing vaginal prolapse surgery." American journal of obstetrics and gynecology 211, no. 5 (November 2014): 554.e1-554.e7.
Dieter, AA, Edenfield, AL, Weidner, AC, Levin, PJ, and Siddiqui, NY. "Does concomitant anterior/apical repair during midurethral sling improve the overactive bladder component of mixed incontinence?." International urogynecology journal 25, no. 9 (September 2014): 1269-1275.
Dieter, AA, Edenfield, AL, Weidner, AC, and Siddiqui, NY. "How does site of pelvic organ prolapse repair affect overactive bladder symptoms?." Female pelvic medicine & reconstructive surgery 20, no. 4 (July 2014): 203-207.
Polin, MR, Edenfield, AL, Dieter, AA, Amundsen, CL, Visco, AG, and Weidner, AC. "PREDICTORS OF POSITIVE PREOPERATIVE URINE CULTURES IN ASYMPTOMATIC WOMEN UNDERGOING UROGYNECOLOGIC SURGERY." INTERNATIONAL UROGYNECOLOGY JOURNAL 25 (July 2014): S146-S147.
Dieter, AA, Weidner, AC, Willis-Gray, M, Visco, AG, and Myers, ER. "TRADITIONAL REPAIR VERSUS MESH AUGMENTATION: ESTIMATING THE TRADE-OFF BETWEEN REOPERATION FOR MESH EXPOSURE VS REOPERATION FOR RECURRENT PROLAPSE." INTERNATIONAL UROGYNECOLOGY JOURNAL 25 (July 2014): S29-S30.
Walter, PJ, Dieter, AA, Siddiqui, NY, Weidner, AC, and Wu, JM. "Perioperative anticholinergic medications and risk of catheterization after urogynecologic surgery." Female pelvic medicine & reconstructive surgery 20, no. 3 (May 2014): 163-167.
Barber, MD, Brubaker, L, Burgio, KL, Richter, HE, Nygaard, I, Weidner, AC, Menefee, SA, Lukacz, ES, Norton, P, Schaffer, J, Nguyen, JN, Borello-France, D, Goode, PS, Jakus-Waldman, S, Spino, C, Warren, LK, Gantz, MG, Meikle, SF, and Eunice Kennedy Shriver National Institute of Child Health and Human Development Pelvic Floor Disorders Network, . "Comparison of 2 transvaginal surgical approaches and perioperative behavioral therapy for apical vaginal prolapse: the OPTIMAL randomized trial." JAMA 311, no. 10 (March 2014): 1023-1034.
Adelowo, A, Hacker, MR, Shapiro, A, Modest, AM, and Elkadry, E. "Botulinum Toxin Type A (BOTOX) for Refractory Myofascial Pelvic Pain." Obstetrical & Gynecological Survey 69, no. 1 (January 2014): 20-21.